quinuclidines has been researched along with Liver Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brealey, N; Hardes, K; Kelleher, D; Mehta, R; Preece, A; Tombs, L | 1 |
| Hoon, T; Krauwinkel, W; Kuipers, M; Smulders, R | 1 |
2 trial(s) available for quinuclidines and Liver Diseases
| Article | Year |
|---|---|
Effects of moderate hepatic impairment on the pharmacokinetic properties and tolerability of umeclidinium and vilanterol in inhalational umeclidinium monotherapy and umeclidinium/vilanterol combination therapy: an open-label, nonrandomized study.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Benzyl Alcohols; Case-Control Studies; Chlorobenzenes; Drug Combinations; Female; Humans; Liver Diseases; Male; Middle Aged; Quinuclidines; Young Adult | 2014 |
Open-label study of the safety and pharmacokinetics of solifenacin in subjects with hepatic impairment.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Female; Follow-Up Studies; Half-Life; Humans; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged; Muscarinic Antagonists; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors | 2006 |